Literature DB >> 21788248

A randomized placebo-controlled cross-over study using a low frequency magnetic field in the treatment of fatigue in multiple sclerosis.

Maria Laura Lopes de Carvalho1, Roberta Motta, Giovanna Konrad, Mario Alberto Battaglia, Giampaolo Brichetto.   

Abstract

BACKGROUND: Fatigue is one of the most common disabling symptoms in multiple sclerosis (MS). There is growing evidence in the literature for beneficial effects of magnetic fields on different MS symptoms and this has been reported to be beneficial in patients with MS, especially those with fatigue.
OBJECTIVES: The aim of the study was to assess the effects on primary fatigue with a pulsed systemic low frequency magnetic field by means of clinical scales in a population of MS subjects.
METHODS: Randomized double-blind cross-over trial with 50 MS subjects with primary fatigue who were recruited among those followed as outpatients at the AISM Rehabilitation Centre, Genova, Italy. Subjects were randomized into two groups: magnetic field group and sham therapy group and evaluated with the Modified Fatigue Impact Scale (MFIS), the Fatigue Severity Scale (FSS), VAS and Time Walking Test 10 meter (TWT10m.) at the time points of the study. Each group received both sham therapy and magnetic field therapy with a wash-out period of 5 months. Subjects were treated for 24 min per session, three times per week, for 8 weeks. Statistical analysis was performed using multivariate analysis.
RESULTS: Results showed a statistically significant improvement in MFIS Physical Score for T0-T1 (p < 0.05) for TIME but not for TREATMENT and TIME*TREATMENT factors. No statistically significant differences were found for all other parameters considered in the study.
CONCLUSIONS: Exposure to a low frequency magnetic field, within the parameters of this treatment protocol, has no advantage over sham exposure in reducing the impact of fatigue.

Entities:  

Mesh:

Year:  2011        PMID: 21788248     DOI: 10.1177/1352458511415748

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  7 in total

Review 1.  Rehabilitation interventions in multiple sclerosis: an overview.

Authors:  Serafin Beer; Fary Khan; Jürg Kesselring
Journal:  J Neurol       Date:  2012-07-08       Impact factor: 4.849

2.  Effect of Comorbidities on Outcomes of Neurorehabilitation Interventions in Multiple Sclerosis: A Scoping Review.

Authors:  Afolasade Fakolade; Etienne J Bisson; Julie Pétrin; Julie Lamarre; Marcia Finlayson
Journal:  Int J MS Care       Date:  2016 Nov-Dec

Review 3.  [New aspects of symptomatic MS treatment: Part 5 - fatigue].

Authors:  T Henze; W Feneberg; P Flachenecker; D Seidel; H Albrecht; M Starck; S G Meuth
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

4.  Light therapy for multiple sclerosis-associated fatigue: a randomized, controlled phase II trial.

Authors:  Farrah J Mateen; Andre C Vogel; Tamara B Kaplan; Gladia C Hotan; Sara J Grundy; Kathryn B Holroyd; Natalie Manalo; Matthew Stauder; Aleksandar Videnovic
Journal:  J Neurol       Date:  2020-04-24       Impact factor: 4.849

5.  Magnetic stimulation supports muscle and nerve regeneration after trauma in mice.

Authors:  Meline N L Stölting; Anne Sophie Arnold; Deana Haralampieva; Christoph Handschin; Tullio Sulser; Daniel Eberli
Journal:  Muscle Nerve       Date:  2016-04       Impact factor: 3.217

6.  Emerging medical applications based on non-ionizing electromagnetic fields from 0 Hz to 10 THz.

Authors:  Mats-Olof Mattsson; Myrtill Simkó
Journal:  Med Devices (Auckl)       Date:  2019-09-12

Review 7.  New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis.

Authors:  Ewa Zielińska-Nowak; Lidia Włodarczyk; Joanna Kostka; Elżbieta Miller
Journal:  J Clin Med       Date:  2020-11-07       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.